Aelis Farma SA (EPA:AELIS)

Aelis Farma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.79	14.05	20.23	34.4	24.71	4.54
Cash & Short-Term Investments	10.79	14.05	20.23	34.4	24.71	4.54
Cash Growth	-14.26%	-30.54%	-41.19%	39.20%	444.51%	-21.37%
Accounts Receivable	0.01	0.47	1.76	1.08	-	-
Other Receivables	2.98	2	1.76	2.69	1.61	1.34
Receivables	3	2.46	3.52	3.77	1.61	1.34
Inventory	-	-	0.05	0.04	0.02	-
Prepaid Expenses	0.33	0.61	0.93	0.31	1.61	0.06
Other Current Assets	-0	1.01	0.14	0.09	0.08	0
Total Current Assets	14.12	18.13	24.87	38.6	28.03	5.94
Property, Plant & Equipment	1.2	1.34	1.18	0.18	0.2	0.05
Other Intangible Assets	0.19	0.19	0.19	0.19	0.09	0.06
Long-Term Deferred Tax Assets	-	-	-	-	-	0.96
Other Long-Term Assets	0.07	0.05	0.04	0.25	-	-
Total Assets	15.58	19.71	26.28	39.22	28.31	7
Accounts Payable	1.03	1.18	4.5	2.42	2.24	0.93
Accrued Expenses	0.31	0.79	0.65	0.58	-	0.3
Short-Term Debt	0	-	0.02	-	-	0.06
Current Portion of Long-Term Debt	1.89	1.31	0.96	0.81	1.14	0.24
Current Portion of Leases	0.16	0.17	0.11	0.01	0.02	0.03
Current Income Taxes Payable	0.03	0.08	0.13	0.08	0.47	-
Current Unearned Revenue	0.7	0.96	3.67	11.88	10.35	-
Other Current Liabilities	0.32	0.32	0	0	-	0.03
Total Current Liabilities	4.43	4.81	10.03	15.78	14.22	1.59
Long-Term Debt	4	3.69	2.05	3.01	6.76	5.99
Long-Term Leases	0.84	0.92	0.9	-	-	0.02
Long-Term Unearned Revenue	0.02	0.04	-	0.58	6.34	-
Other Long-Term Liabilities	0.17	0.14	0.1	0.06	0.1	0.11
Total Liabilities	9.47	9.59	13.08	19.43	27.41	7.71
Common Stock	0.14	0.14	0.13	0.05	0	0
Additional Paid-In Capital	16.01	-	-	-	-	6.63
Retained Earnings	-4.32	-	-	-	-	-2.78
Comprehensive Income & Other	-4.37	9.98	13.07	19.74	0.9	-4.56
Shareholders' Equity	6.11	10.12	13.2	19.79	0.9	-0.71
Total Liabilities & Equity	15.58	19.71	26.28	39.22	28.31	7
Total Debt	6.89	6.08	4.04	3.82	7.92	6.34
Net Cash (Debt)	3.9	7.97	16.19	30.57	16.79	-1.8
Net Cash Growth	-47.99%	-50.79%	-47.04%	82.06%	-	-
Net Cash Per Share	0.29	0.59	1.26	2.58	1.75	-0.19
Filing Date Shares Outstanding	13.67	13.59	13.18	12.6	9.59	9.59
Total Common Shares Outstanding	13.67	13.59	13.18	12.6	9.59	9.59
Working Capital	9.68	13.32	14.84	22.82	13.81	4.35
Book Value Per Share	0.45	0.74	1.00	1.57	0.09	-0.07
Tangible Book Value	5.92	9.93	13.01	19.6	0.81	-0.77
Tangible Book Value Per Share	0.43	0.73	0.99	1.56	0.08	-0.08

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.